Gram-negative rosacea

From WikiMD's WELLNESSPEDIA


Gram-negative rosacea
Synonyms
Pronounce N/A
Specialty Dermatology
Symptoms Facial redness, pustules, papules
Complications
Onset
Duration
Types N/A
Causes Overgrowth of Gram-negative bacteria
Risks Long-term antibiotic use
Diagnosis Clinical evaluation, bacterial culture
Differential diagnosis Acne vulgaris, rosacea, perioral dermatitis
Prevention N/A
Treatment Topical antibiotics, oral antibiotics
Medication Metronidazole, clindamycin, ciprofloxacin
Prognosis
Frequency Rare
Deaths N/A


Gram-negative rosacea is a rare and severe form of rosacea, a chronic skin condition, that is characterized by the presence of Gram-negative bacteria. This condition is often resistant to standard rosacea treatments and may require more aggressive therapy.

Symptoms[edit]

The symptoms of Gram-negative rosacea are similar to those of other forms of rosacea, but they are often more severe. They may include:

Causes[edit]

The exact cause of Gram-negative rosacea is unknown, but it is thought to be related to an overgrowth of Gram-negative bacteria on the skin. Other factors that may contribute to the development of this condition include:

Diagnosis[edit]

Diagnosis of Gram-negative rosacea is typically made based on the patient's symptoms and a physical examination of the skin. In some cases, a skin biopsy may be performed to confirm the diagnosis and rule out other conditions.

Treatment[edit]

Treatment for Gram-negative rosacea often involves a combination of oral and topical antibiotics to target the Gram-negative bacteria. In severe cases, isotretinoin may be used. It's important to note that treatment can be challenging and may require a trial-and-error approach.

Prognosis[edit]

The prognosis for Gram-negative rosacea varies. Some people may experience a complete resolution of symptoms with treatment, while others may have persistent or recurrent symptoms.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.